InvestorsHub Logo
Followers 5
Posts 582
Boards Moderated 0
Alias Born 12/04/2012

Re: porkypigg post# 24268

Thursday, 02/28/2013 4:28:04 PM

Thursday, February 28, 2013 4:28:04 PM

Post# of 50672
They must just dilute the living hell out of their stock, there is no reason for a company with a drug in phase II clinical trials to be valued so low though. The market cap is a little small considering the potential revenues for their drug. But the way it seems they dilute their shares when ever the price goes up isn't exactly a good way to build investor confidence. All IMO of course.